Osmosis Investment Takes $1.63 Million Stake in Salesforce

Osmosis Investment Management UK Ltd has taken on a significant stake in Salesforce Inc. (NYSE:CRM), purchasing approximately $1.63 million worth of shares during the second quarter.

The fund acquired 10,398 shares of CRM stock, according to its latest filing with the Securities and Exchange Commission (SEC).

This move is not an isolated instance; other large investors have also made notable adjustments to their positions in Salesforce. Temasek Holdings Private Ltd boosted its holdings in CRM by 3.7% during the fourth quarter.

Analysts' views on Salesforce are mixed, with some expressing optimism about the company's AI opportunity and earnings outlook. BTIG Research has reaffirmed its Buy rating and set a $255 price target for CRM shares.